SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
02-Mar-20 7:26 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-20 | Grant | 30,000 | -- | -- | 52% 58.13K to 88.13K | |
02-Mar-20 7:26 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-20 | Market Sale | 3,454 | $8.70 | $30,049.80 | (4%) 88.13K to 84.68K | 65% |
12-Apr-19 4:00 PM View: | Akebia Therapeutics, Inc. (AKBA) | 11-Apr-19 | Disposition | 6,075 | $7.70 | $46,777.50 | (10%) 61.4K to 55.32K | 61% |
05-Mar-19 10:00 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-19 | Grant | 30,000 | -- | -- | 96% 31.4K to 61.4K | |
13-Dec-18 8:18 AM View: | Akebia Therapeutics, Inc. (AKBA) | 12-Dec-18 | Payment of Exercise | 11,928 | $8.94 | $106,636.00 | (28%) 42.16K to 30.23K | 66% |
02-Mar-18 4:14 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-18 | Grant | 17,500 | -- | -- | 73% 24.02K to 41.52K | |
23-Feb-17 4:02 PM View: | Akebia Therapeutics, Inc. (AKBA) | 21-Feb-17 | Grant | 23,000 | -- | -- | 100% 0 to 23.0K | |
29-Jun-16 4:16 PM View: | Carisma Therapeutics Inc. (CARM) | 27-Jun-16 | Market Sale | 4,372 | $2.08 | $9,093.76 | (12%) 37.13K to 32.75K | 43% |
30-Dec-15 4:04 PM View: | Carisma Therapeutics Inc. (CARM) | 28-Dec-15 | Market Sale | 4,427 | $2.85 | $12,616.90 | (12%) 37.4K to 32.97K | 61% |
29-Jun-15 4:07 PM View: | Carisma Therapeutics Inc. (CARM) | 26-Jun-15 | Grant | 37,400 | -- | -- | 100% 0 to 37.4K |